Antibody desensitization therapy in highly sensitized lung transplant candidates. - Wikidata - wikimedia - TriplyDB

Antibody desensitization therapy in highly sensitized lung transplant candidates.

Antibody desensitization therapy in highly sensitized lung transplant candidates.

http://www.wikidata.org/entity/Q33414196

about

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: Does it work?Advances in pharmacotherapy to treat kidney transplant rejection.Humoral Compensation after Bortezomib Treatment of Allosensitized Recipients.Pre-transplant Panel Reactive Antibody and Survival in Adult Cystic Fibrosis Patients After Lung Transplantation.Prevention of chronic rejection after lung transplantation.The IVIg dilemma.Human Leukocyte Antigen Sensitization in Solid Organ Transplantation: A Primer on Terminology, Testing, and Clinical Significance for the Apheresis Practitioner.Critical updates in the 7th edition of the American Society for Apheresis guidelines.HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction.New frontiers in immunosuppression.

P2860

Q30276550-E0E0D86B-F53C-4569-9D15-B0E6F089DE75 Q33437712-182840A7-B3AA-4280-AE46-6BFA931C18C7 Q38544529-1037E877-0B4A-4A6F-AEFB-ACFD941E4C9D Q38945149-6E1AF4C9-BDD1-4F3E-8821-D537FF66A7B3 Q39955219-2042D7DB-BAEC-4E15-8BFE-0605D5A8279B Q47662940-52F493A6-3CC4-4959-A440-93B11795F82F Q47813529-14391E60-7CA4-40A9-BCB2-A19B1FEE8D1B Q48112929-54503D2E-6B6A-4F84-B5A1-05D79260D26E Q48217985-26B10A17-1527-46E5-88FF-3C20CF745A1B Q50247563-8903D0B3-8835-4F7A-8881-E5519802AB74 Q55547403-E0418AB2-D257-4353-8710-5D1E450EB9D4

P2860

Antibody desensitization therapy in highly sensitized lung transplant candidates.

http://www.wikidata.org/entity/Q33414196

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Antibody desensitization therapy in highly sensitized lung transplant candidates.

@ast

Antibody desensitization therapy in highly sensitized lung transplant candidates.

@en

type

label

Antibody desensitization therapy in highly sensitized lung transplant candidates.

@ast

Antibody desensitization therapy in highly sensitized lung transplant candidates.

@en

prefLabel

Antibody desensitization therapy in highly sensitized lung transplant candidates.

@ast

Antibody desensitization therapy in highly sensitized lung transplant candidates.

@en

P1433

Q33414196-EC294334-E7CC-40A4-BF3A-7255ABEC4573

P1476

Q33414196-94C32004-59B9-4C65-BEED-3D5EF195DA0B

P2093

Q33414196-2B026B96-AD26-463F-B2DE-8D486D2D2374

Q33414196-2C62F1E0-6D3C-4FCE-A938-CE87A38C680C

Q33414196-2F46B98C-8ED5-4D3A-9054-D7A49FAC2AE1

Q33414196-42E16505-168C-47D4-A024-DF55994EA4CC

Q33414196-7927BCA1-10BF-4D7B-A171-822BE6E84D69

Q33414196-7BE07E55-7D6D-4AD2-90F6-8443F136E2B3

Q33414196-A4C3C788-06D3-4DE3-B781-E87206DB511D

Q33414196-AAEC95C4-D58E-4286-9C04-5EB423D918CE

Q33414196-B3B0FE8C-B5B2-4121-8F7C-9D1F652AB75C

P2860

Q33414196-12B84609-7B5A-41C0-BAE4-8311F38D3027

Q33414196-20290B83-AC64-4A62-B44D-471F39C49E21

Q33414196-39E8AF9B-B081-443A-8C72-E048B51370D0

Q33414196-3D68DA38-212A-4373-B6EA-FA713B46C7E6

Q33414196-70204755-66A2-4446-B4D3-1A0F2DD3FBF4

Q33414196-736FCD97-E0F0-4AF9-8B1F-D499145152FC

Q33414196-7D53CF9A-A1F9-4666-ABF4-A3FDA6F39F46

Q33414196-7D9C1E00-F903-468F-988B-960E7B64BCF4

Q33414196-9BB85172-5B4A-495F-9F99-15E2C5665C3C

Q33414196-A46D0390-5A26-4C9C-B4C6-9E6A6564D4EB

P304

Q33414196-784537DF-2CFA-4E04-A577-8EE1E1239143

P31

Q33414196-C6B56A27-0A0E-4DBE-9C44-5EF1B8C08743

P356

Q33414196-2BE4C650-E94C-4F05-BA42-8EB155D44DDC

P407

Q33414196-C1664E3F-D87B-4890-9356-BFFD52FD1C30

P433

Q33414196-B364BE29-246C-4260-B55F-BB6ACB9DBBEE

P478

Q33414196-A94E1847-907A-42D3-94DC-0A67185DEE05

P50

Q33414196-0E7CE0CC-BB3C-4880-8502-BB8902FF7AAC

Q33414196-C3C0CEF9-B757-4631-BFF1-9A3C35E111FB

P577

Q33414196-03C63A1A-6E54-4994-B2D2-C8DB6B0BB3B6

P698

Q33414196-7190A6F4-4CE2-4D62-9CC4-25F41B47D19A

P921

Q33414196-FDBEF211-7A7A-4D3D-A49F-977A508FA131

P932

Q33414196-1EAA12E8-ACDB-470F-816B-2B195C8FF521

P356

P1433

American Journal of Transplantation

P1476

Antibody desensitization therapy in highly sensitized lung transplant candidates

@en

P2093

A L Gray

http://www.w3.org/2001/XMLSchema#string

D F Chen

http://www.w3.org/2001/XMLSchema#string

G M Arepally

http://www.w3.org/2001/XMLSchema#string

J M Reynolds

http://www.w3.org/2001/XMLSchema#string

K E Lopes

http://www.w3.org/2001/XMLSchema#string

M G Hartwig

http://www.w3.org/2001/XMLSchema#string

R D Davis

http://www.w3.org/2001/XMLSchema#string

S M Palmer

http://www.w3.org/2001/XMLSchema#string

W E Wegner

http://www.w3.org/2001/XMLSchema#string

P2860

Lung transplantation is warranted for stable, ventilator-dependent recipients.

Active rehabilitation during extracorporeal membrane oxygenation as a bridge to lung transplantation.

Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients

Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients.

Desensitization: achieving immune detente.

Pretransplant panel reactive antibodies in human lung transplantation: an analysis of over 10,000 patients.

Desensitization protocol using bortezomib for highly sensitized patients awaiting heart or lung transplants.

Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.

Therapeutic preparations of IVIg contain naturally occurring anti-HLA-E antibodies that react with HLA-Ia (HLA-A/-B/-Cw) alleles.

Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study.

P304

849-856

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJT.12636

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Laurie D Snyder

P577

2014-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24666831

http://www.w3.org/2001/XMLSchema#string

P921

lung transplant

P932

4336170

http://www.w3.org/2001/XMLSchema#string